{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:13:48Z","timestamp":1790734428349,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.hrthm.2025.02.038","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T12:00:07Z","timestamp":1740571207000},"page":"e492-e499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-1313","authenticated-orcid":false,"given":"Larisa G.","family":"Tereshchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Muchai","family":"Manyara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Ciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Olufemi","family":"Sodeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chastity N.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Santangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir R.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Wazni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv M.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet S.","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Bilchick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Huizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marmar","family":"Vaseghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.02.038_bib1","article-title":"Reporting of surrogate endpoints in RANDOMISED controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration","volume":"386","author":"Manyara","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.02.038_bib2","article-title":"Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration","volume":"386","author":"Manyara","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.02.038_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102283","article-title":"A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials","volume":"65","author":"Ciani","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.hrthm.2025.02.038_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3284","article-title":"Assessment of clinical trials supporting US Food and Drug Administration approval of novel therapeutic agents, 1995-2017","volume":"3","author":"Zhang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2025.02.038_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.2013.282034","article-title":"Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005\u20132012","volume":"311","author":"Downing","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.02.038_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12454","article-title":"Analysis of supportive evidence for US Food and Drug Administration approvals of novel drugs in 2020","volume":"5","author":"Mitra-Majumdar","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2025.02.038_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1467-9868.2007.00617.x","article-title":"Criteria for surrogate end points","volume":"69","author":"Chen","year":"2007","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.hrthm.2025.02.038_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f457","article-title":"Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study","volume":"346","author":"Ciani","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.02.038_bib9","article-title":"Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE","volume":"12","author":"Manyara","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.hrthm.2025.02.038_bib10","article-title":"Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol","volume":"12","author":"Manyara","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.hrthm.2025.02.038_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate end points in clinical trials: are we being misled?","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Cardiac Arrhythmia Suppression Trial I. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Cardiac Arrhythmia Suppression Trial III. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJM197412192912504","article-title":"Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients","volume":"291","author":"Lie","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(81)91116-8","article-title":"Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials","volume":"2","author":"DeSilva","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.02.038_bib17","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1001\/archinte.1989.00390120056011","article-title":"Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction","volume":"149","author":"Hine","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib18","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.1988.03410130118036","article-title":"Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials","volume":"260","author":"MacMahon","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.02.038_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.02.038_bib20","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2025.02.038_bib21","doi-asserted-by":"crossref","unstructured":"VanderWeele T. Explanation in Causal Inference: Methods for Mediation and Interaction. Oxford University Press; 2015.","DOI":"10.1093\/ije\/dyw277"},{"key":"10.1016\/j.hrthm.2025.02.038_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(13)62228-X","article-title":"Reducing waste from incomplete or unusable reports of biomedical research","volume":"383","author":"Glasziou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.02.038_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(13)62329-6","article-title":"Biomedical research: increasing value, reducing waste","volume":"383","author":"Macleod","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.02.038_bib24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jclinepi.2014.04.001","article-title":"Active implementation strategy of CONSORT adherence by a dental specialty journal improved randomized clinical trial reporting","volume":"67","author":"Pandis","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2025.02.038_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jebm.12616","article-title":"Five aspects of research waste in biomedicine: a scoping review","volume":"17","author":"Rosengaard","year":"2024","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","article-title":"Avoidable waste in the production and reporting of research evidence","volume":"374","author":"Chalmers","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.02.038_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jclinepi.2023.06.013","article-title":"Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review","volume":"160","author":"Manyara","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2025.02.038_bib28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/pst.2219","article-title":"Informed decision-making: statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments","volume":"21","author":"Weir","year":"2022","journal-title":"Pharm Stat"},{"key":"10.1016\/j.hrthm.2025.02.038_bib29","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/hex.13272","article-title":"Patients as partners in health research: a scoping review","volume":"24","author":"McCarron","year":"2021","journal-title":"Health Expect"},{"key":"10.1016\/j.hrthm.2025.02.038_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106740","article-title":"Inclusion and diversity in clinical trials: actionable steps to drive lasting change","volume":"116","author":"Kelsey","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.hrthm.2025.02.038_bib31","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJMp2215609","article-title":"Why diverse clinical trial participation matters","volume":"388","author":"Schwartz","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib32","first-page":"169","article-title":"A systematic scoping review of adherence to reporting guidelines in health care literature","volume":"6","author":"Samaan","year":"2013","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.hrthm.2025.02.038_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026589","article-title":"Scoping review on interventions to improve adherence to reporting guidelines in health research","volume":"9","author":"Blanco","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.hrthm.2025.02.038_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12916-015-0460-y","article-title":"Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial","volume":"13","author":"Barnes","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001566","article-title":"Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals","volume":"10","author":"Riveros","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.hrthm.2025.02.038_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008681","article-title":"How do scientists perceive the current publication culture? A qualitative focus group interview study among Dutch biomedical researchers","volume":"6","author":"Tijdink","year":"2016","journal-title":"BMJ Open"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125002097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125002097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:56:40Z","timestamp":1756933000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125002097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1547527125002097"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.038","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}